SCHEMBL5964702

SCHEMBL5964702

Cc1ccc(F)c(C(=O)n2nc(Nc3ccc(S(=O)(=O)NCCN(C)C)cc3)nc2N)c1F

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 15/20 0.82
▸ CCNB2 O95067 8/20 0.82
▸ CCNB1 P14635 8/20 0.82
▸ CCNB3 Q8WWL7 8/20 0.82
▸ CDK2 P24941 10/20 0.60
▸ CDK4 P11802 3/20 0.60
▸ CCNA2 P20248 3/20 0.60
▸ FGFR2 P21802 3/20 0.60
▸ CCND1 P24385 3/20 0.60
▸ MAPK3 P27361 3/20 0.60
▸ MAPK1 P28482 3/20 0.60
▸ KDR P35968 3/20 0.60
▸ GSK3A P49840 3/20 0.60
▸ GSK3B P49841 3/20 0.60
▸ CCNA1 P78396 3/20 0.60
▸ EGFR P00533 2/20 0.60
▸ INSR P06213 2/20 0.60
▸ JAK1 P23458 5/20 0.55
▸ TYK2 P29597 5/20 0.55
▸ JAK3 P52333 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5964667 0.91 CDK1 (1.00) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL5726353 0.86 CDK1 (0.68) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL5726923 0.85 CDK1 (0.67) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL5726498 0.84 CDK1 (0.71) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL5727292 0.84 CDK1 (0.83) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL5725945 0.82 CDK1 (0.72) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL5964764 0.81 CDK1 (0.71) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL5964771 0.80 CDK1 (0.65) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL7089472 0.79 CDK1 (0.78) CDK1CCNB2CCNB1CCNB3CDK2
SCHEMBL12755109 0.77 CDK1 (0.72) CDK1CCNB2CCNB1CCNB3CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1712550-A2 Substituted triazole diamine derivatives as kinase inhibitors Ortho-McNeil Pharmaceutical, Inc. (US) 2006-10-18 — — EP disclosed
Send feedback